Want to see HK:1846 full AI Analyst Report?
1846 Stock Chart & Stats
HK$3.00
-HK$0.02(-0.53%)
At close: 4:00 PM EST
HK$3.00
-HK$0.02(-0.53%)
Day’s Range― - ―
52-Week RangeHK$2.30 - HK$3.46
Previous CloseN/A
Volume15.00K
Average Volume (3M)156.72K
Market Cap
HK$780.25M
Enterprise ValueHK$470.71M
Total Cash (Recent Filing)HK$696.70M
Total Debt (Recent Filing)HK$410.19M
Price to Earnings (P/E)14.3
Beta0.18
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)0.17
Shares Outstanding320,706,000
10 Day Avg. Volume164,000
30 Day Avg. Volume156,720
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.78
Price to Sales (P/S)1.22
P/FCF Ratio6.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Elective Vision-care Business ModelEuroEyes’ core business is elective, procedure-based eye care—refractive and lens procedures—which delivers per-procedure revenue and repeatable patient flows. Reputation-driven demand for elective vision correction supports long-term volume resilience and pricing power versus one-off services.
Consistent Operating Cash GenerationStable, positive operating cash flow and rising free cash flow in 2025 underpin the company’s ability to fund capex, service debt, and sustain distributions. Durable cash generation reduces reliance on external financing and provides flexibility across business cycles.
Sizable Equity And Historically Manageable LeverageA strong equity base relative to assets provides a capital buffer that supports clinic operations and strategic optionality. Historically modest leverage gives room to absorb shocks or pursue investments without immediate solvency pressure, enhancing financial resilience.
Bears Say
Sharply Lower ROE And ProfitabilityThe marked decline in ROE signals weaker capital efficiency and reduced ability to convert equity into earnings. Persistently lower returns can constrain reinvestment, limit shareholder distributions, and indicate structural margin or pricing pressure if not reversed.
Rising Total Debt In 2025Higher absolute debt raises interest and fixed-charge burdens, reducing financial flexibility. With profitability down, incremental leverage heightens refinancing and coverage risks, limiting capacity for expansion or absorbing demand shocks over the medium term.
Margin Compression And Weaker Earnings QualityEarnings declined while revenue rose, indicating margin pressure from cost increases or mix shifts. Lower operating profitability reduces cash conversion potential and raises the risk that earnings are more volatile, impairing long-term reinvestment and returns.
EuroEyes International Eye Clinic Limited News
1846 FAQ
What was EuroEyes International Eye Clinic Limited’s price range in the past 12 months?
EuroEyes International Eye Clinic Limited lowest stock price was HK$2.30 and its highest was HK$3.46 in the past 12 months.
What is EuroEyes International Eye Clinic Limited’s market cap?
EuroEyes International Eye Clinic Limited’s market cap is HK$780.25M.
When is EuroEyes International Eye Clinic Limited’s upcoming earnings report date?
EuroEyes International Eye Clinic Limited’s upcoming earnings report date is Aug 27, 2026 which is in 55 days.
How were EuroEyes International Eye Clinic Limited’s earnings last quarter?
EuroEyes International Eye Clinic Limited released its earnings results on Mar 31, 2026. The company reported HK$0.05 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.05.
Is EuroEyes International Eye Clinic Limited overvalued?
According to Wall Street analysts EuroEyes International Eye Clinic Limited’s price is currently Overvalued.
Does EuroEyes International Eye Clinic Limited pay dividends?
EuroEyes International Eye Clinic Limited pays a Quarterly dividend of HK$0.013 which represents an annual dividend yield of 1.99%. See more information on EuroEyes International Eye Clinic Limited dividends here
What is EuroEyes International Eye Clinic Limited’s EPS estimate?
EuroEyes International Eye Clinic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EuroEyes International Eye Clinic Limited have?
EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding.
What happened to EuroEyes International Eye Clinic Limited’s price movement after its last earnings report?
EuroEyes International Eye Clinic Limited reported an EPS of HK$0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.372%.
Which hedge fund is a major shareholder of EuroEyes International Eye Clinic Limited?
Currently, no hedge funds are holding shares in HK:1846
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EuroEyes International Eye Clinic Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.87%
12-Months-Change
Fundamentals
Return on Equity
4.33%
Trailing 12-Months
Asset Growth
22.06%
Trailing 12-Months
Company Description
EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, the People’s Republic of China, Denmark, and the United Kingdom. The company offers laser eye surgery in various options, including SMILE Pro, Femto-Lasik, PRK, and Lasek; refractive laser surgery, such as ReLEx SMILE, Femto LASIK, and Presbyond; lens exchange surgery comprising monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also sells pharmaceutical products; rental of ophthalmic equipment and operating spaces; and provides training service. In addition, the company is involved in the operation of consultation centers and/or clinics for eye treatment, as well as LASIK centers; and trading of eye clinic equipment and lenses. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
Technical Analysis
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―
Options Prices
Currently, No data available
---